In patients with AATD, there appears to be an increased risk of cytoplasmic antineutrophil cytoplasmic antibody (C-ANCA)-associated vasculitis, which is supported by plausible pathogenetic mechanisms. The gene discussed is PRTN3; the disease is alpha 1-antitrypsin deficiency.